| My Account | Subscribe | Contact Us | Donate |
Home
- The Edmonton Protocol and Me
- Olympia Dukakis and Her Husband Tackle Type 2
- Surfing with Type 1
- Behind the Wheel, But Still in Control
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Type 2 Medications Articles
Save A Few Billion: Buy Generic Drugs
Aug 26, 2007
Americans spend 275 billion dollars on prescription medicines every single year, sixty percent of it on generics. But in the next five years, the twenty-year patents are going to expire on enough brand-name medicines to account for about 60 billion dollars of that total. And the generics that spring up to replace those drugs will be thirty to eighty percent cheaper.
It's good news for everyone who takes medicine, except maybe for the 22 percent who don't trust generics to be as good as brand names. Perhaps they're equating generic drugs to knock-offs of other products, like clothing, which may not measure up to the original name brand. But when it comes to drugs, it's important to remember that the FDA makes sure that generics meet the same quality standards as the brand names. They're just as good, so you may as well save the money.
Source: The New York Times
Editor's Note: My health plan charges me a larger co-pay for my insulin, Levemir and Novolog, even though no generic insulins yet exist. Their policy of charging a premium for a brand name even when a generic isn't available does not seem quite kosher. Let's hope that generic insulins make it to the market soon. (For more on that possibility, see "Why Does Insulin Cost More Than Ever? It's All In The Way It's Made", May 2007.)
Categories: Beginners, Insulin, Medications, Professional Issues, Type 1 Issues, Type 2 Issues, Type 2 Medications
Facebook
MySpace 
Digg
You May Also Be Interested In...
Click Here To View Or Post Comments
Aug 26, 2007 -
Email to a Friend
Send a link to this page to your friends and colleagues.